Overview
CODROIPO_BELVEDERE wastewater treatment plant serves Codroipo, Friuli-Venezia Giulia, Italy. It treats wastewater for approximately 2,602 people and has a designed capacity of 1.00 unit.
The CODROIPO_BELVEDERE wastewater treatment plant is located in Codroipo, in the Friuli-Venezia Giulia region of northeastern Italy. The facility serves a population of approximately 2,602 residents, operating as part of the municipal wastewater infrastructure for the area. As a small-scale treatment plant, it falls under the regulatory framework of the EU Urban Waste Water Treatment Directive (91/271/EEC), which requires appropriate treatment for agglomerations of this size. The plant discharges treated wastewater into local water bodies that ultimately drain into the Adriatic Sea via the Tagliamento River basin. This region is ecologically sensitive, supporting diverse aquatic life and contributing to the health of the northern Adriatic coastal ecosystem.
Environmental context
The plant's treated effluent likely enters the local drainage network within the Tagliamento River basin, one of the last morphologically intact river systems in the Alps. The Tagliamento flows into the Gulf of Venice in the northern Adriatic Sea, an area known for its rich biodiversity and important fisheries. Proper treatment is essential to protect downstream habitats and water quality.
Frequently asked questions
The plant is located at Via Casali Belvedere, Passariano, in Codroipo, Udine province, Friuli-Venezia Giulia, Italy.
The plant serves approximately 2,602 people in the Codroipo area.
Treated wastewater is discharged into local water bodies within the Tagliamento River basin, which flows into the Adriatic Sea.
As an Italian plant, it operates under the EU Urban Waste Water Treatment Directive (91/271/EEC), which sets treatment standards based on population served and receiving water sensitivity.
Under the EU directive, agglomerations under 2,000 population equivalent require appropriate treatment, while those above 2,000 generally require secondary treatment. For 2,600 people, secondary treatment is typically expected.
Nearby plants